Kostmann&;s syndrome-treatment is
**Core Concept**
Kostmann's syndrome, also known as severe congenital neutropenia, is a rare genetic disorder characterized by a deficiency of neutrophils, a type of white blood cell essential for fighting infections. This condition is caused by mutations in the ELA2 gene, leading to impaired neutrophil production and function.
**Why the Correct Answer is Right**
The treatment for Kostmann's syndrome typically involves administering granulocyte colony-stimulating factor (G-CSF) to stimulate the production and release of neutrophils from the bone marrow. This helps to increase the number of neutrophils in the blood and improves the body's ability to fight infections. G-CSF works by binding to its receptor on the surface of bone marrow cells, triggering a signaling cascade that leads to increased production of neutrophils.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because corticosteroids are not a primary treatment for Kostmann's syndrome. While corticosteroids may be used to manage certain symptoms or complications, they do not address the underlying neutropenia.
**Option B:** This option is incorrect because antibiotics are not a primary treatment for Kostmann's syndrome. While antibiotics may be used to treat secondary infections, they do not improve the underlying neutropenia.
**Option C:** This option is incorrect because hematopoietic stem cell transplantation is a treatment option for some cases of Kostmann's syndrome, but it is not the first-line treatment. G-CSF therapy is typically the initial treatment of choice.
**Clinical Pearl / High-Yield Fact**
Kostmann's syndrome is a rare but serious condition that highlights the importance of proper diagnosis and treatment of congenital neutropenia. Early recognition and initiation of G-CSF therapy can significantly improve outcomes for patients with this condition.
**Correct Answer:** C. G-CSF therapy.